Akebia Therapeutics, Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Akebia Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Akebia Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -20.6 %, a 1.25% increase year-over-year.
  • Akebia Therapeutics, Inc. annual Return On Assets for 2023 was -20.5 %, a 1.99% decline from 2022.
  • Akebia Therapeutics, Inc. annual Return On Assets for 2022 was -20.1 %, a 57.7% increase from 2021.
  • Akebia Therapeutics, Inc. annual Return On Assets for 2021 was -47.6 %, a 11.9% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -20.5 -0.4 -1.99% Jan 1, 2023 Dec 31, 2023
2022 -20.1 +27.4 +57.7% Jan 1, 2022 Dec 31, 2022
2021 -47.6 +6.4 +11.9% Jan 1, 2021 Dec 31, 2021
2020 -54 -19.9 -58.2% Jan 1, 2020 Dec 31, 2020
2019 -34.1 -8.65 -34% Jan 1, 2019 Dec 31, 2019
2018 -25.5 -2.76 -12.2% Jan 1, 2018 Dec 31, 2018
2017 -22.7 +38.6 +63% Jan 1, 2017 Dec 31, 2017
2016 -61.3 -18 -41.7% Jan 1, 2016 Dec 31, 2016
2015 -43.2 -13.1 -43.5% Jan 1, 2015 Dec 31, 2015
2014 -30.1 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.